-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Sage Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to Q1 2025.
- Sage Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $148K, a 90.5% decline year-over-year.
- Sage Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $10.7M, a 76.9% increase from 2023.
- Sage Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.03M, a 96.3% increase from 2022.
- Sage Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.07M, a 77% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)